Heart safety check for new cholesterol drug in healthy volunteers
NCT ID NCT06411860
Summary
This study aimed to see if a single dose of the experimental drug olpasiran (AMG 890) causes any changes to the electrical activity of the heart in healthy people. It involved 32 healthy adult volunteers who received the drug, a placebo, and a control medication in a specific order. The main goal was to measure the drug's effect on the QT interval, a part of the heart's electrical cycle, to ensure it does not pose a risk of dangerous heart rhythms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BASIC SCIENCE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fortrea Clinical Research Unit Limited - Leeds
Leeds, LS11 9EH, United Kingdom
Conditions
Explore the condition pages connected to this study.